Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

30

Revenue 2017

Botox/Neuromodulator

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Botox/Neuromodulator was produced by Allergan.

FTC clears AbbVie’s $63bn Allergan takeover

FTC clears AbbVie’s $63bn Allergan takeover

Last June, AbbVie announced that it had agreed to acquire Allergan and its blockbuster drug Botox in a $63bn buyout, but the companies have since faced a rocky road on the

Pharma funding and M&A in 2020

Pharma funding and M&A in 2020 a cool $63bn (which was also notable for putting the world’s best-selling drug Humira under the same roof as Botox).

Lundbeck gets US approval for migraine drug at heart of Alder takeover

Lundbeck gets US approval for migraine drug at heart of Alder takeover specialists aren’t rushing to switch wholesale from other migraine preventative therapies like Allergan’s Botox.

20 for 2020 – Five pharma companies to watch

20 for 2020 – Five pharma companies to watch year. Botox is facing tougher competition in the market from new migraine drugs as well as rivals in its medical aesthetics indications. ... The latter is still low level, however, and biosimilars to Botox are thought to be some years off the market.

Revenue growth at Ipsen numbs pain of palovarotene calamity

Revenue growth at Ipsen numbs pain of palovarotene calamity as Dysport (abobotulinumtoxinA), a rival to Allergan’s big-selling Botox brand.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Fishawack Group of Companies

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...

Latest intelligence

ACCOMPLISH MEANINGFUL HCP ENGAGEMENT ONLINE
The art of delivering valuable customer journeys aligned to your key messages in 2020...
DEMAND DIVERSITY REPORT 01: Exploring attitudes towards clinical research among people from different ethnic groups in the UK
This report reveals insights from the people themselves, and discusses the starting points for overcoming current challenges....
Why are new medicinal products denied reimbursement in France?
Many medicinal products looking to launch are rejected for reimbursement in France. A manufacturer must convince the Transparency Committee that their product is safe, effective and offers added value relative...

Infographics